The UCSF study identified a window of 30 to 35 days post surgery, following surgery in patients with glioblastoma multiforme, when delayed radiation significantly improved OS and PFS.
Patients with newly diagnosed (GBM) have significantly better overall survival when there is a short delay between surgery and the start of radiation therapy, investigators say.
The optimal time to start radiation in patients with GBM is controversial, with some studies showing worse outcomes among patients for whom therapy is delayed and others suggesting that a short delay may not be harmful or may even be beneficial, said Seunggu Han, MD, a neurosurgery resident at the University of California San Francisco (UCSF), at the Congress of Neurological Surgeons (CNS) 2014 Annual Meeting here.
"With most other malignancies — , lung cancer — it's very clear that even if you delay radiation a little bit, outcomes are significantly worse, but it's beginning to look like it's not quite the same for glioblastoma," he said in an interview with Medscape Medical News.
Read the complete article on Medscape: http://bit.ly/1vUdeyJ
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More